Nanotech France 2017 Conference and Exhibition
Nanotech France 2017
28 - 30 Jun 2017 | Paris France
Dr. Katti's research is focused on unraveling the fundamentals of science as he applies those principles and new concepts in developing new chemical species at the macro and nano scales. In the ‘nano-domain’, he is interested in exploring biophysical, chemical, magnetic, nuclear and photophysical properties, that are unique to specific nanoparticulates, toward the design and development of sophisticated diagnostic and therapeutic agents. Targeted nanoparticles, which are created through the intervention of ‘Katti Peptides’ are being utilized in the detection of diseases at the cellular/sub cellular levels while radiochemical and X ray absorption properties of gold nanoparticles, embedded selectively within tumor cells/sites, are being applied for effective therapy of breast, liver, lung, oral, prostate and pancreatic cancers and various debilitating diseases which include Osteoarthritis and Parkinson’s diseases. Drug discovery approaches are built around a clinical translation motif as Dr. Katti strongly believes that discoveries should translate into value added products to ultimately serve humanity across the globe.
Green nanotechnology is at the focal point of Dr. Katti's approach to pursuing research in nanotechnology (and molecular medicine) as he strongly believes in the total elimination of toxic chemicals in the production of engineered nanoparticles. Toward this end, phytochemicals occluded within plants, herbs or from various sources from Mother Nature are being used as electron reservoirs in developing 100% green processes for the development of nano constructs, and a spectrum of molecular medicine-conjugates, for use in a plethora of medical, agricultural, hygienic (antibacterial/antimicrobial) and technological applications.